The role of bonds in a crisis

By Lora Benson | Apr 20, 2020
The coronavirus crisis has raised questions about the diversification benefits of fixed income securities. We explore their role as shock absorbers during periods of market stress.

By Giulio Renzi-Ricci, senior investment strategist, Vanguard Europe.

The economic repercussions of the Covid-19 pandemic have brought sharp declines in equity markets in recent weeks, with investors looking to their bond exposures to cushion some of the blow. In March, however, the value of fixed income securities and funds fell across a wide range of durations and currencies. For example, the Vanguard Global Bond Index Fund (GBP hedged), which tracks a representative global basket of high-grade bonds, was down 1.9% in March. 

Even the traditional ‘safe haven’ of developed market government bonds failed to provide refuge from the market turbulence in this period, with yield curves rising at certain periods to compound investor pain. The Bloomberg Barclays Global Aggregate Treasuries index (GBP hedged) was down -0.17% in March. While the Bloomberg Barclays Gilt index rose 1.52%, developed market government bonds in many regions fell, with the Bloomberg Barclays Germany and France Treasuries (GBP hedged) indices down -1.26% and -2.71%, respectively.
 
The simultaneous fall in both bonds and equities has raised questions about the diversification benefits of fixed income securities and their role as shock absorbers during periods of market distress.

The rationale for maintaining a balance between bonds and equities is based on the understanding that bond returns tend to move in the opposite direction to equity returns. A healthy exposure to bond markets should provide investors with a cushion to absorb some of the losses when equity markets inevitably tumble. This feature is normally enhanced for longer-duration bonds as highlighted by Figure 1.
 
Figure 1. Performance of government bond indices for different durations during worst quartile of equity performance


Past performance is not a reliable indicator of future results.Sources: FTSE All-World Index in GBP and Bloomberg Barclays Global Treasury (GBP Hedged) indices. Data from 31 January 1999 to 31 March 2020.


So, why were bond valuations falling at the same time as equities? And does that mean that the relationship that we have been relying on for asset allocation is dead and that bonds no longer play the role of risk diversifiers in a multi-asset portfolio? 

One of the observable trends during distressed markets is the ‘flight to quality’, but in the case of the Covid-19 pandemic we have seen a ‘flight to cash’. By that we mean investors are selling their equity and higher-risk bond (high-yield) positions, holding the cash and waiting for the volatility and uncertainty to reduce.
 

Similarly, asset managers facing redemptions tend to sell their most liquid assets first, which are typically developed market government bonds and high-quality corporate bonds. This has put further downward pressure on bond prices as it happened in tandem with the economic reaction to the spread of Covid-19 (e.g., layoffs, declines in growth as a result of the containment measures). Although difficult to forecast, the flight to cash is likely to be temporary, and once market confidence bounces back and investors buy back into marginally riskier assets, the correction could be sharp.

Another explanation is that the large fiscal packages that have been rolled out in the US and Europe have put upward pressure on government bond yields as markets price in the added credit risk associated with more borrowing. If the fiscal stimulus works, though, we should see a reversion in government bond yields over the next couple of months.

In fact, we should think about why equity and bond returns tend to move in opposite directions. The conditions for that to hold are related to how monetary policy responds to equity sell-offs. Over the past 20 years or more, since central banks widely adopted inflation-targeting policies, they have responded to economic growth shocks by rapidly lowering interest rates (and therefore bond yields), which ultimately pushes bond returns up. This is exactly how central banks have been responding to the Covid-19 shock.

Of course, this dynamic does work less effectively when interest rates are already low, as in the current economic environment. When yields are already very low, there is less room for them to decrease further and therefore bonds provide less downside protection compared to a high interest rate environment. But even then, they still provide some protection. 

High market volatility is the result of many variables impacting the market at the same time, including irrational human behaviour. With that in mind, we can’t expect the negative correlation in equity and bond prices to hold each and every day, but rather on average over the investment horizon. For now, there is no reason to abandon the long-standing position that bonds will perform their duty as shock absorbers in multi-asset portfolios.
 
Visit Vanguard’s adviser briefings content hub to view their latest live webinars, in-depth articles, and regularly updated commentary designed to guide you through the crisis.

Investment risk information:

The value of investments, and the income from them, may fall or rise and investors may get back less than they invested.

Past performance is not a reliable indicator of future results.

Funds investing in fixed interest securities carry the risk of default on repayment and erosion of the capital value of your investment and the level of income may fluctuate. Movements in interest rates are likely to affect the capital value of fixed interest securities. Corporate bonds may provide higher yields but as such may carry greater credit risk increasing the risk of default on repayment and erosion of the capital value of your investment. The level of income may fluctuate and movements in interest rates are likely to affect the capital value of bonds.

 

Important information
This document is directed at professional investors and should not be distributed to, or relied upon by retail investors. This document is designed for use by, and is directed only at, persons resident in the UK.  

The material contained in this document is not to be regarded as an offer to buy or sell or the solicitation of any offer to buy or sell securities in any jurisdiction where such an offer or solicitation is against the law, or to anyone to whom it is unlawful to make such an offer or solicitation, or if the person making the offer or solicitation is not qualified to do so. The information in this document does not constitute legal, tax, or investment advice. You must not, therefore, rely on the content of this document when making any investment decisions.

Vanguard Investment Series plc has been authorised by the Central Bank of Ireland as a UCITS and has been registered for public distribution in certain EU countries.

Prospective investors are referred to the Funds’ prospectus for further information. Prospective investors are also urged to consult their own professional advisers on the implications of making an investment in, and holding or disposing shares of the Funds and the receipt of distributions with respect to such shares under the law of the countries in which they are liable to taxation.  

The Manager of Vanguard Investment Series plc is Vanguard Group (Ireland) Limited.  Vanguard Asset Management, Limited is a distributor of Vanguard Investment Series plc.

For further information on the funds investment policy, please refer to the Key Investor Information Document (.KIIDs.). The KIIDs for these funds are available in local languages, alongside the prospectus via Vanguard.s website https://global.vanguard.com/.

BLOOMBERG® is a trademark and service mark of Bloomberg Finance L.P. BARCLAYS® is a trademark and service mark of Barclays Bank Plc, used under license. Bloomberg Finance L.P. and its affiliates, including Bloomberg Index Services Limited ("BISL") (collectively, "Bloomberg"), or Bloomberg's licensors own all proprietary rights in the Bloomberg Barclays Indices. 

The products are not sponsored, endorsed, issued, sold or promoted by “Bloomberg or Barclays”. Bloomberg and Barclays make no representation or warranty, express or implied, to the owners or purchasers of the products or any member of the public regarding the advisability of investing in securities generally or in the products particularly or the ability of the Bloomberg Barclays Indices to track general bond market performance. Neither Bloomberg nor Barclays has passed on the legality or suitability of the products with respect to any person or entity. Bloomberg’s only relationship to Vanguard and the products are the licensing of the Bloomberg Barclays Indices which are determined, composed and calculated by BISL without regard to Vanguard or the products or any owners or purchasers of the products. Bloomberg has no obligation to take the needs of the products or the owners of the products into consideration in determining, composing or calculating the Bloomberg Barclays Indices. Neither Bloomberg nor Barclays is responsible for and has not participated in the determination of the timing of, prices at, or quantities of the products to be issued. Neither Bloomberg nor Barclays has any obligation or liability in connection with the administration, marketing or trading of the products.

The opinions expressed in this presentation are those of individual speakers and may not be representative of Vanguard Asset Management, Limited.

Issued by Vanguard Asset Management, Limited which is authorised and regulated in the UK by the Financial Conduct Authority. © 2020 Vanguard Asset Management, Limited. All rights reserved.